PlainRecalls
FDA Drug Low Class III Terminated

RIVASTIGMINE Tartrate Capsules, USP, 1.5 mg, 60-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally 500-900 India, NDC 55111-352-60

Reported: April 12, 2017 Initiated: March 6, 2017 #D-0649-2017

Product Description

RIVASTIGMINE Tartrate Capsules, USP, 1.5 mg, 60-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally 500-900 India, NDC 55111-352-60

Reason for Recall

Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.

Details

Units Affected
1,728 bottles
Distribution
U.S. nationwide
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
RIVASTIGMINE Tartrate Capsules, USP, 1.5 mg, 60-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally 500-900 India, NDC 55111-352-60. Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: 1,728 bottles.
Why was this product recalled?
Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 12, 2017. Severity: Low. Recall number: D-0649-2017.